Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

14.3%

2 terminated out of 14 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

29%

4 trials in Phase 3/4

Results Transparency

20%

2 of 10 completed with results

Key Signals

2 with results83% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (2)
Early P 1 (1)
P 2 (2)
P 3 (1)
P 4 (3)

Trial Status

Completed10
Terminated2
Recruiting1
Not Yet Recruiting1

Trial Success Rate

83.3%

Benchmark: 86.6%

Based on 10 completed trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT07596680Early Phase 1Not Yet Recruiting

CD19/BCMA-Targeted Universal CAR-T Cell Injection for the Treatment of Autoimmune Diseases

NCT03905525Phase 2CompletedPrimary

Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's Syndrome

NCT06411132TerminatedPrimary

Study to Evaluate Corneal Neurosensory Abnormalities in Patients With Sjögren's Dry Eye

NCT04793646Not ApplicableCompletedPrimary

N-acetylcysteine for Primary Sjögren's Syndrome

NCT04848870RecruitingPrimary

Dental and Periodontal Status of Patients With Sjögren's Syndrome.

NCT04819269Phase 3Completed

Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome

NCT03762824Phase 4Completed

Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease

NCT04035668Phase 2TerminatedPrimary

A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome

NCT05079581Not ApplicableCompleted

Pelvic Floor Exercises in Patients With Sjögren's

NCT03941184Completed

Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity

NCT02752269CompletedPrimary

Early Detection of Pulmonary- and Pulmonary Vascular Disease in Sjögren Syndrome

NCT03608761Phase 4Completed

Comparison Between Rebamipide 2% Versus Autologous Serum

NCT02011776Completed

A Randomized, Parallel-Group Comparison Study of Topical Corticosteroids in Dry Eye Patients With Sjögren Syndrome

NCT02049112Phase 4Completed

A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study

Showing all 14 trials

Research Network

Activity Timeline